{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:01:04Z","timestamp":1791979264260,"version":"4.4.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"13","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100030692","name":"Intramural Research Program, National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["NIH-HEAL-U24DA058673"],"award-info":[{"award-number":["NIH-HEAL-U24DA058673"]}],"id":[{"id":"10.13039\/100030692","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s11606-026-10531-2","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:12:33Z","timestamp":1780326753000},"page":"3817-3827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Clinical Instruments Assessing Harms and Benefits of Long-Term Opioid Therapy for Chronic Pain: A Scoping Review"],"prefix":"10.1007","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-7601-6449","authenticated-orcid":false,"given":"Alexis D.","family":"Grant","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moid","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa C.","family":"Funaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne C.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Esserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn L.","family":"DeBar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Edmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"10531_CR1","doi-asserted-by":"publisher","unstructured":"Lyu X, Guy GP, Baldwin GT, Losby JL, Bohnert ASB, Goldstick JE. State-to-State Variation in Opioid Dispensing Changes Following the Release of the 2016 CDC Guideline for Prescribing Opioids for Chronic Pain. JAMA Network Open. 2023;6(9):e2332507. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.32507.","DOI":"10.1001\/jamanetworkopen.2023.32507"},{"key":"10531_CR2","doi-asserted-by":"publisher","unstructured":"Dowell D, Haegerich TM, Chou R. CDC Guideline for Prescribing Opioids for Chronic Pain\u2014United States, 2016. JAMA. 2016;315(15):1624. https:\/\/doi.org\/10.1001\/jama.2016.1464.","DOI":"10.1001\/jama.2016.1464"},{"key":"10531_CR3","doi-asserted-by":"publisher","unstructured":"Becker WC, Fraenkel L, Edelman JE, Holt SR, Glover J, Kerns RD, Fiellin DA. Instruments to assess patient-reported safety, efficacy, or misuse of current opioid therapy for chronic pain: a systematic review. Pain. 2013:154(6):905\u2013916. https:\/\/doi.org\/10.1016\/j.pain.2013.02.031.","DOI":"10.1016\/j.pain.2013.02.031"},{"key":"10531_CR4","doi-asserted-by":"publisher","unstructured":"Dowell D, Ragan KR, Jones CM, Baldwin GT, Chou R.\u00a0CDC Clinical Practice Guideline for Prescribing Opioids for Pain\u2014United States, 2022. MMWR Recommen Rep. 2022:71(3):1\u201395. https:\/\/doi.org\/10.15585\/mmwr.rr7103a1.","DOI":"10.15585\/mmwr.rr7103a1"},{"key":"10531_CR5","doi-asserted-by":"publisher","unstructured":"Cohen SP, Hooten WM. Balancing the Risks and Benefits of Opioid Therapy: The Pill and the Pendulum. Mayo Clinic Proc. 2019;94(12):2385\u20132389. https:\/\/doi.org\/10.1016\/j.mayocp.2019.10.006.","DOI":"10.1016\/j.mayocp.2019.10.006"},{"key":"10531_CR6","unstructured":"Lembke A, Humphreys K, Newmark J. Weighing the Risks and Benefits of Chronic Opioid Therapy. Am Fam Physician. 2016;93(12):982\u2013990."},{"key":"10531_CR7","doi-asserted-by":"publisher","unstructured":"Arksey H, O\u2019Malley L. Scoping studies: Towards a methodological framework. Int J Soc Res Methodol. 2005;8(1):19\u201332. https:\/\/doi.org\/10.1080\/1364557032000119616.","DOI":"10.1080\/1364557032000119616"},{"key":"10531_CR8","doi-asserted-by":"publisher","unstructured":"Ove Hansson S. Weighing Risks and Benefits. Topoi. 2004;23(2):145\u2013152. https:\/\/doi.org\/10.1007\/s11245-004-5371-z.","DOI":"10.1007\/s11245-004-5371-z"},{"key":"10531_CR9","doi-asserted-by":"publisher","unstructured":"Mt-Isa S, Tzoulaki I, Callr\u00e9us T, Micaleff A, Ashby D. Weighing benefit\u2013risk of medicines: Concepts and approaches. Drug Discov Today Technol. 2011;8(1):e29\u2013e35. https:\/\/doi.org\/10.1016\/j.ddtec.2011.04.002.","DOI":"10.1016\/j.ddtec.2011.04.002"},{"key":"10531_CR10","doi-asserted-by":"publisher","unstructured":"Ashby D, Smith AFM.\u00a0Evidence-based medicine as Bayesian decision-making. Stat Med. 2000;19(23):3291\u20133305. https:\/\/doi.org\/10.1002\/1097-0258(20001215)19:23%253C3291::AID-SIM627%253E3.0.CO;2-T.","DOI":"10.1002\/1097-0258(20001215)19:23%253C3291::AID-SIM627%253E3.0.CO;2-T"},{"key":"10531_CR11","doi-asserted-by":"publisher","unstructured":"Henrie-Barrus P, Averill LA, Sudweeks RR, Averill CL, Mota N.\u00a0Development and preliminary validation of the Opioid Abuse Risk Screener. Health Psychol Open. 2016;3(1):2055102916648995. https:\/\/doi.org\/10.1177\/2055102916648995.","DOI":"10.1177\/2055102916648995"},{"key":"10531_CR12","doi-asserted-by":"publisher","unstructured":"Oliva EM, Bowe T, Tavakoli S, Martins S, Lewis ET, Paik M, Wiechers I, Henderson P, Harvey M, Avoundjian T, Medhanie A, Trafton JA.\u00a0Development and applications of the Veterans Health Administration\u2019s Stratification Tool for Opioid Risk Mitigation (STORM) to improve opioid safety and prevent overdose and suicide. Psych Serv. 2017;14(1):34\u201349. https:\/\/doi.org\/10.1037\/ser0000099.","DOI":"10.1037\/ser0000099"},{"key":"10531_CR13","unstructured":"FDA identifies harm reported from sudden discontinuation of opioid pain medicines and requires label changes to guide prescribers on gradual, individualized tapering.\u00a02019.\u00a0https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-identifies-harm-reported-sudden-discontinuation-opioid-pain-medicines-and-requires-label-changes."},{"key":"10531_CR14","unstructured":"VA\/DoD Clinical Practice Guideline: Use of Opioids in the Management of Chronic Pain Work Group.\u00a02022. Washington, DC: U.S. Government Printing Office."},{"key":"10531_CR15","doi-asserted-by":"publisher","unstructured":"Bergman AA, Matthias MS, Coffing JM, Krebs EE.\u00a0Contrasting Tensions Between Patients and PCPs in Chronic Pain Management: A Qualitative Study: Table 1. Pain Med. 2013;14(11):1689\u20131697. https:\/\/doi.org\/10.1111\/pme.12172.","DOI":"10.1111\/pme.12172"},{"key":"10531_CR16","doi-asserted-by":"publisher","unstructured":"Swan K, Speyer R, Scharitzer M, Farneti D, Brown T, Woisard V, Cordier R.\u00a0Measuring what matters in healthcare: A practical guide to psychometric principles and instrument development. Front Psychol. 2023;14:1225850. https:\/\/doi.org\/10.3389\/fpsyg.2023.1225850.","DOI":"10.3389\/fpsyg.2023.1225850"},{"key":"10531_CR17","doi-asserted-by":"publisher","unstructured":"Connell J, Carlton J, Grundy A, Taylor Buck E, Keetharuth AD, Ricketts T, Barkham M, Robotham D, Rose D, Brazier J.\u00a0The importance of content and face validity in instrument development: Lessons learnt from service users when developing the Recovering Quality of Life measure (ReQoL). Qual Life Res. 2018;27(7):1893\u20131902. https:\/\/doi.org\/10.1007\/s11136-018-1847-y.","DOI":"10.1007\/s11136-018-1847-y"},{"key":"10531_CR18","doi-asserted-by":"publisher","unstructured":"Nicolson KP, Mills SEE, Senaratne DNS, Colvin LA, Smith BH. What is the association between childhood adversity and subsequent chronic pain in adulthood? A systematic review. BJA Open. 2023;6:100139. https:\/\/doi.org\/10.1016\/j.bjao.2023.100139.","DOI":"10.1016\/j.bjao.2023.100139"},{"key":"10531_CR19","doi-asserted-by":"publisher","unstructured":"Wu SM, Compton P, Bolus R, Schieffer B, Pham Q, Baria A, Van Vort W, Davis F, Shekelle P, Naliboff BD. The Addiction Behaviors Checklist: Validation of a New Clinician-Based Measure of Inappropriate Opioid Use in Chronic Pain. J Pain Symptom Manag. 2006;32(4):342\u2013351. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.05.010.","DOI":"10.1016\/j.jpainsymman.2006.05.010"},{"key":"10531_CR20","doi-asserted-by":"publisher","unstructured":"Lutz J, Gross R, Long D, Cox S.\u00a0Predicting Risk for Opioid Misuse in Chronic Pain with a Single-Item Measure of Catastrophic Thinking. J Am Board Fam Med. 2017;30(6):828\u2013831. https:\/\/doi.org\/10.3122\/jabfm.2017.06.170124.","DOI":"10.3122\/jabfm.2017.06.170124"},{"key":"10531_CR21","doi-asserted-by":"publisher","unstructured":"Mallery Lankford C, Paez K, Yang M, Lin A. Adapting the Current Opioid Misuse Measure (COMM) for people with chronic pain and disability due to arthritis: The development of the COMM 11-PWDA. Disabil Health J. 2022;15(2):101296. https:\/\/doi.org\/10.1016\/j.dhjo.2022.101296.","DOI":"10.1016\/j.dhjo.2022.101296"},{"key":"10531_CR22","doi-asserted-by":"publisher","unstructured":"McCaffrey SA, Black RA, Villapiano AJ, Jamison RN, Butler SF.\u00a0Development of a Brief Version of the Current Opioid Misuse Measure (COMM): The COMM-9. Pain Med. 2019;20(1):113\u2013118. https:\/\/doi.org\/10.1093\/pm\/pnx311.","DOI":"10.1093\/pm\/pnx311"},{"key":"10531_CR23","doi-asserted-by":"publisher","unstructured":"Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, Jamison RN. Development and validation of the Current Opioid Misuse Measure. Pain. 2007:130(1\u20132):144\u2013156. https:\/\/doi.org\/10.1016\/j.pain.2007.01.014.","DOI":"10.1016\/j.pain.2007.01.014"},{"key":"10531_CR24","doi-asserted-by":"publisher","unstructured":"Barth KS, Balliet W, Pelic CM, Madan A, Malcolm R, Adams D, Morgan K, Owczarski S, Borckardt JJ.\u00a0Screening for Current Opioid Misuse and Associated Risk Factors among Patients with Chronic Nonalcoholic Pancreatitis Pain. Pain Med. 2014;15(8):1359\u20131364. https:\/\/doi.org\/10.1111\/pme.12403.","DOI":"10.1111\/pme.12403"},{"key":"10531_CR25","doi-asserted-by":"publisher","unstructured":"Meltzer EC, Rybin D, Saitz R, Samet JH, Schwartz SL, Butler SF, Liebschutz JM.\u00a0Identifying prescription opioid use disorder in primary care: Diagnostic characteristics of the Current Opioid Misuse Measure (COMM). Pain. 2011;152(2):397\u2013402. https:\/\/doi.org\/10.1016\/j.pain.2010.11.006.","DOI":"10.1016\/j.pain.2010.11.006"},{"key":"10531_CR26","doi-asserted-by":"publisher","unstructured":"Belgrade MJ, Schamber CD, Lindgren BR. The DIRE Score: Predicting Outcomes of Opioid Prescribing for Chronic Pain. J Pain. 2006;7(9):671\u2013681. https:\/\/doi.org\/10.1016\/j.jpain.2006.03.001.","DOI":"10.1016\/j.jpain.2006.03.001"},{"key":"10531_CR27","doi-asserted-by":"publisher","unstructured":"You DS, Mardian AS, Darnall BD, Chen CYA, De Bruyne K, Flood PD, Kao MC, Karnik AD, McNeely J, Porter JG, Schwartz RP, Stieg RL, Mackey SC.\u00a0A Brief Screening Tool for Opioid Use Disorder: EMPOWER Study Expert Consensus Protocol. Front Med. 2021;8:591201. https:\/\/doi.org\/10.3389\/fmed.2021.591201.","DOI":"10.3389\/fmed.2021.591201"},{"key":"10531_CR28","doi-asserted-by":"publisher","unstructured":"Jamison RN, Martel MO, Huang CC, Jurcik D, Edwards RR.\u00a0Efficacy of the Opioid Compliance Checklist to Monitor Chronic Pain Patients Receiving Opioid Therapy in Primary Care. J Pain. 2016;17(4):414\u2013423. https:\/\/doi.org\/10.1016\/j.jpain.2015.12.004.","DOI":"10.1016\/j.jpain.2015.12.004"},{"key":"10531_CR29","doi-asserted-by":"publisher","unstructured":"Webster LR, Webster RM. Predicting aberrant behaviors in opioid-treated patients: Preliminary validation of the Opioid Risk Tool. Pain Med (Malden, Mass.). 2005;6(6):432\u2013442. https:\/\/doi.org\/10.1111\/j.1526-4637.2005.00072.x.","DOI":"10.1111\/j.1526-4637.2005.00072.x"},{"key":"10531_CR30","doi-asserted-by":"publisher","unstructured":"Jones T, Passik SD. A comparison of methods of administering the opioid risk tool. J Opioid Manag. 2011;7(5):347\u2013351. https:\/\/doi.org\/10.5055\/jom.2011.0075.","DOI":"10.5055\/jom.2011.0075"},{"key":"10531_CR31","doi-asserted-by":"publisher","unstructured":"Cheatle MD, Compton PA, Dhingra L, Wasser TE, O\u2019Brien CP.\u00a0Development of the Revised Opioid Risk Tool to Predict Opioid Use Disorder in Patients with Chronic Nonmalignant Pain. J Pain. 2019;20(7):842\u2013851. https:\/\/doi.org\/10.1016\/j.jpain.2019.01.011.","DOI":"10.1016\/j.jpain.2019.01.011"},{"key":"10531_CR32","doi-asserted-by":"publisher","unstructured":"Larance B, Bruno R, Lintzeris N, Degenhardt L, Black E, Brown A, Nielsen S, Dunlop A, Holland R, Cohen M, Mattick RP.\u00a0Development of a brief tool for monitoring aberrant behaviours among patients receiving long-term opioid therapy: The Opioid-Related Behaviours In Treatment (ORBIT) scale. Drug Alcohol Depend. 2016;159:42\u201352. https:\/\/doi.org\/10.1016\/j.drugalcdep.2015.11.026.","DOI":"10.1016\/j.drugalcdep.2015.11.026"},{"key":"10531_CR33","doi-asserted-by":"publisher","unstructured":"Passik S.\u00a0A new tool to assess and document pain outcomes in chronic pain patients receiving opioid therapy. Clin Ther. 2004;26(4):552\u2013561. https:\/\/doi.org\/10.1016\/S0149-2918(04)90057-4.","DOI":"10.1016\/S0149-2918(04)90057-4"},{"key":"10531_CR34","doi-asserted-by":"publisher","unstructured":"Adams LL, Gatchel RJ, Robinson RC, Polatin P, Gajraj N, Deschner M, Noe C.\u00a0Development of a self-report screening instrument for assessing potential opioid medication misuse in chronic pain patients. J Pain Symptom Manag. 2004;27(5):440\u2013459. https:\/\/doi.org\/10.1016\/j.jpainsymman.2003.10.009.","DOI":"10.1016\/j.jpainsymman.2003.10.009"},{"key":"10531_CR35","doi-asserted-by":"publisher","unstructured":"Holmes CP, Gatchel RJ, Adams LL, Stowell AW, Hatten A, Noe C, Lou L.\u00a0An Opioid Screening Instrument: Long\u2010Term Evaluation of the Utility of the Pain Medication Questionnaire. Pain Pract. 2006;6(2):74\u201388. https:\/\/doi.org\/10.1111\/j.1533-2500.2006.00067.x.","DOI":"10.1111\/j.1533-2500.2006.00067.x"},{"key":"10531_CR36","doi-asserted-by":"publisher","unstructured":"Becker WC, Fiellin DA, Black AC, Kostovich CT, Kerns RD, Fraenkel L.\u00a0Initial development of patient-reported instrument assessing harm, efficacy, and misuse of long-term opioid therapy. J Rehabil Res Dev. 2016;53(1):127\u2013136. https:\/\/doi.org\/10.1682\/JRRD.2014.11.0285.","DOI":"10.1682\/JRRD.2014.11.0285"},{"key":"10531_CR37","doi-asserted-by":"publisher","unstructured":"Sullivan MD, Von Korff M, Banta-Green C, Merrill JO, Saunders K.\u00a0Problems and concerns of patients receiving chronic opioid therapy for chronic non-cancer pain. Pain. 2010;149(2):345\u2013353. https:\/\/doi.org\/10.1016\/j.pain.2010.02.037.","DOI":"10.1016\/j.pain.2010.02.037"},{"key":"10531_CR38","doi-asserted-by":"publisher","unstructured":"Banta-Green CJ, Von Korff M, Sullivan MD, Merrill JO, Doyle SR, Saunders K.\u00a0The Prescribed Opioids Difficulties Scale: A Patient-centered Assessment of Problems and Concerns. Clin J Pain. 2010;26(6):489\u2013497. https:\/\/doi.org\/10.1097\/AJP.0b013e3181e103d9.","DOI":"10.1097\/AJP.0b013e3181e103d9"},{"key":"10531_CR39","doi-asserted-by":"publisher","unstructured":"Compton P, Darakjian J, Miotto K.\u00a0Screening for addiction in patients with chronic pain and \u201cproblematic\u201d substance use: Evaluation of a pilot assessment tool. J Pain Symptom Manag. 1998;16(6):355\u2013363. https:\/\/doi.org\/10.1016\/s0885-3924(98)00110-9.","DOI":"10.1016\/s0885-3924(98)00110-9"},{"key":"10531_CR40","doi-asserted-by":"publisher","unstructured":"Banta-Green CJ, Merrill JO, Doyle SR, Boudreau DM, Calsyn DA. Measurement of opioid problems among chronic pain patients in a general medical population. Drug Alcohol Depend. 2009;104(1\u20132):43\u201349. https:\/\/doi.org\/10.1016\/j.drugalcdep.2009.03.022.","DOI":"10.1016\/j.drugalcdep.2009.03.022"},{"key":"10531_CR41","doi-asserted-by":"publisher","unstructured":"Compton PA, Wu SM, Schieffer B, Pham Q, Naliboff BD. Introduction of a self-report version of the Prescription Drug Use Questionnaire and relationship to medication agreement noncompliance. J Pain Symptom Manag. 2008;36(4):383\u2013395. https:\/\/doi.org\/10.1016\/j.jpainsymman.2007.11.006.","DOI":"10.1016\/j.jpainsymman.2007.11.006"},{"key":"10531_CR42","doi-asserted-by":"publisher","unstructured":"Coyne KS, Barsdorf AI, Currie BM, Poon JL, Mazi\u00e8re JY, Pierson RF, Butler SF, Schnoll SH, Farrar JT, Fisher HJ, Franks MJ. Insight into chronic pain in the United States: Descriptive results from the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ) validation study. Curr Med Res Opin. 2021;37(3):483\u2013492. https:\/\/doi.org\/10.1080\/03007995.2020.1865889.","DOI":"10.1080\/03007995.2020.1865889"},{"key":"10531_CR43","doi-asserted-by":"publisher","unstructured":"Coyne KS, Barsdorf AI, Mazi\u00e8re JY, Pierson RF, Lanza ST, Farrar JT, Gelfand CHJ, Porter LN, Schnoll SH, Butler SF.\u00a0Identification of prescription opioid misuse and abuse behaviors and risk factors in chronic pain patients using the Prescription Opioid Misuse and Abuse Questionnaire (POMAQ). Curr Med Res Opin. 2023;39(3):441\u2013450. https:\/\/doi.org\/10.1080\/03007995.2023.2174343.","DOI":"10.1080\/03007995.2023.2174343"},{"key":"10531_CR44","doi-asserted-by":"publisher","unstructured":"Coloma-Carmona A, Carballo JL.\u00a0Assessing Opioid Abuse in Chronic Pain Patients: Further Validation of the Prescription Opioid Misuse Index (POMI) Using Item Response Theory. Int J Ment Health Addict. https:\/\/doi.org\/10.1007\/s11469-023-01029-7.","DOI":"10.1007\/s11469-023-01029-7"},{"key":"10531_CR45","doi-asserted-by":"publisher","unstructured":"Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED.\u00a0Prescription Opioid Misuse Index: A brief questionnaire to assess misuse. J Subst Abuse Treat. 2008;35(4):380\u2013386. https:\/\/doi.org\/10.1016\/j.jsat.2008.02.001.","DOI":"10.1016\/j.jsat.2008.02.001"},{"key":"10531_CR46","doi-asserted-by":"publisher","unstructured":"Nielsen S, Picco L, Kowalski M, Sanfilippo P, Wood P, Larney S, Bruno R, Ritter A. Routine opioid outcome monitoring in community pharmacy: Outcomes from an open-label single-arm implementation-effectiveness pilot study.\u00a0Res Social Adm Pharm. 2020;16(12):1694\u2013701. https:\/\/doi.org\/10.1016\/j.sapharm.2020.02.009.","DOI":"10.1016\/j.sapharm.2020.02.009"},{"key":"10531_CR47","doi-asserted-by":"publisher","unstructured":"Butler SF, Budman SH, Fernandez K, Jamison RN.\u00a0Validation of a screener and opioid assessment measure for patients with chronic pain. Pain. 2004;112(1):65\u201375. https:\/\/doi.org\/10.1016\/j.pain.2004.07.026.","DOI":"10.1016\/j.pain.2004.07.026"},{"key":"10531_CR48","doi-asserted-by":"publisher","unstructured":"Akbik H, Butler SF, Budman SH, Fernandez K, Katz NP, Jamison RN. Validation and Clinical Application of the Screener and Opioid Assessment for Patients with Pain (SOAPP). J Pain Symptom Manag. 2006;32(3):287\u2013293. https:\/\/doi.org\/10.1016\/j.jpainsymman.2006.03.010.","DOI":"10.1016\/j.jpainsymman.2006.03.010"},{"key":"10531_CR49","doi-asserted-by":"publisher","unstructured":"Black RA, McCaffrey SA, Villapiano AJ, Jamison RN, Butler SF. Development and Validation of an Eight-Item Brief Form of the SOAPP-R (SOAPP-8). Pain Med. 2018;19(10):1982\u20131987. https:\/\/doi.org\/10.1093\/pm\/pnx194.","DOI":"10.1093\/pm\/pnx194"},{"key":"10531_CR50","doi-asserted-by":"publisher","unstructured":"Butler SF, Fernandez K, Benoit C, Budman SH, Jamison RN. Validation of the Revised Screener and Opioid Assessment for Patients With Pain (SOAPP-R). J\u00a0Pain 9(4):360\u2013372. https:\/\/doi.org\/10.1016\/j.jpain.2007.11.014.","DOI":"10.1016\/j.jpain.2007.11.014"},{"key":"10531_CR51","doi-asserted-by":"publisher","unstructured":"Friedman R, Li V, Mehrotra D. Treating pain patients at risk: Evaluation of a screening tool in opioid-treated pain patients with and without addiction. Pain Med (Malden, Mass.). 2003;4(2):182\u2013185. https:\/\/doi.org\/10.1046\/j.1526-4637.2003.03017.x.","DOI":"10.1046\/j.1526-4637.2003.03017.x"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-026-10531-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-026-10531-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:14:18Z","timestamp":1790885658000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-026-10531-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":51,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10531"],"URL":"https:\/\/doi.org\/10.1007\/s11606-026-10531-2","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"12 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to declare.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}